FAST NEWS: Drug Discovery Business Helps Viva Biotech Swing Back to Profit
The latest: Viva Biotech Holdings (1873.HK) released a positive profit forecast, saying it posted a net profit of 300 million yuan ($48.2 million) or more last year, reversing a loss…
RELATED ARTICLES
-
Cash-strapped Viva Biotech sells stake and plans spinoff
1873.HK
- FAST NEWS: Viva Biotech completes Langhua Pharma buyout
- InSilico seeks IPO boost to get AI drugs over the line
-
GenScript losses shrink on strong growth for cancer cell therapy
1548.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
Discover hidden China stock gems in our weekly newsletter